Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Insecticides India - Revenue mix improvement expands margins - ICICI Securities

Posted On: 2021-06-21 16:24:44 (Time Zone: UTC)


Takeaways from Insecticides India's Q4FY21: (1) 25.2% increase in Institutional sales and 18.7% increase in other branded sales resulted in revenue growth of 7.1%, YoY. However, branded product sales grew just 3.3%, (2) Insecticides has reduced net working capital days to 131 now vs 147 at FY20-end. The company has also reduced its debt with improvement in cash collections and (3) EBITDA margin improved 1,230bps YoY due to better product mix. We remain positive on Insecticides due to (1) steady launches of high-margin products, (2) removal of generic products from the portfolio and (3) backward integration of technical. We maintain ADD rating on the stock with revised DCF based target price of Rs800 (13x FY23E, Earlier TP-Rs521).

- Q4FY21 result: Revenue was up 7.1% YoY, EBITDA and PAT turned positive, against negative in Q4FY20. Gross and EBITDA margin expanded 1110bps and 1230bps, respectively. Due to improvement in revenue mix (increase in branded products 3% YoY, other branded products 18.7% YoY) and lower input prices, the EBITDA margin expanded 1230bps YoY.

- Segment-wise performance: Sales of branded products increased 3% in Q4FY21, YoY. During FY21, branded products sales were flat, while Maharatna products grew of 3.7% over FY20, contributing 46% of branded sales. Institutional sales were up 19.7% YoY. Exports were flat during FY21. The new products launched from FY13 onwards contributed ~35.7% of the revenues

- Higher focus on cash collections: The company has focussed on reducing the investments in net working capital and higher cash collection during the quarter. Net working capital days of the company now stands at 131 compared to 147 at the end of FY20. With improvement in cash collections, the company has reduced its debt.

- Aggressive new product launches to drive growth: The company launched 7 new products in Maharatna category in FY21 and plans to launch 5-6 new products to drive growth in FY22. It secured a new patent in fungicides in FY21. It will be sold under the brand name SOFIA.

- Maintain ADD: We model Insecticides to report revenue and PAT CAGRs of 8.6% and 10.6%, respectively, over FY21-FY23E. Return ratios are also expected to improve over the same timeframe. We maintain ADD rating on the stock. At our DCF-based target price of Rs800, the implied P/E works out to 13x FY23E. Key risk: Weaker-than-expected performance of new product launches and higher competition.

Shares of INSECTICIDES (INDIA) LTD. was last trading in BSE at Rs.757.75 as compared to the previous close of Rs. 750.45. The total number of shares traded during the day was 27438 in over 1801 trades.

The stock hit an intraday high of Rs. 780 and intraday low of 742.75. The net turnover during the day was Rs. 20928260.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

Ambuja Cements Ltd: Q2CY21 Result update - YES Securities

Q1FY22 Result Update - Polycab India - ICICI Direct

Q1FY22 Result Update - Hindustan Zinc - ICICI Direct

Federal Bank - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - Biocon Ltd - ICICI Direct

IPO Review - Glenmark Life Sciences Ltd - ICICI Direct

JSW Steel - Q1FY22 First Cut - ICICI Direct

Crompton Greaves Consumer Electricals - Q1FY22 First Cut - ICICI Direct

Q1FY22 Result Update - CSB Bank - ICICI Direct

SKF India - Q1FY22 First Cut - ICICI Direct

Company Update - Gandhi Special Tubes - ICICI Direct

Q1FY22 Result Update - Hindustan Unilever - ICICI Direct

Q1FY22 Company Update - Mphasis - ICICI Direct

Maintain REDUCE on Hindustan Unilever - Steady performance continues - HDFC Securities

Maintain ADD on Havells India - Robust performance despite the odds - HDFC Securities

Maintain BUY on Bajaj Auto - Laying the ground for future technologies - HDFC Securities

Maintain BUY on UltraTech Cement - UltraHigh! Margin at its best ever; outlook strong - HDFC Securities

ICICI Lombard Report - Not in the pink: spike in health claims affects loss ratio - HDFC Securities

Hindustan Zinc - Higher commodity continues to propel earnings - ICICI Securities

ICICI Lombard General Insurance Company - Q1FY22 Update - ICICI Direct

UltraTech Cement - EBITDA/te inches to highest-ever Rs1,600/te - ICICI Securities

Arvind Fashions Ltd - A step in the right direction - ICICI Securities

CEAT - RM cost pressures likely to stay elevated - ICICI Securities

Hindustan Unilever - (Re) Investing (margins) for growth - ICICI Securities

Mahindra CIE Automotive - Growth outlook remains healthy - ICICI Securities

Bajaj Auto - Tough quarter; export outlook remains solid - ICICI Securities

Mphasis - Q1 FY22 first cut - YES Securities

Can Fin Homes - Q1 FY22 first cut - YES Securities

Sterlite Technologies - Q1 FY22 first cut - YES Securities

IndiaMart - Q1 FY22 first cut (Current Rating: BUY) - YES Securities

Schaeffler Q2CY21 call highlights (Rating: NOT RATED) - YES Securities

CEAT 1QFY22 call highlights (Rating: NOT RATED) - YES Securities

Bajaj Auto 1QFY22 first cut & call highlights (Rating: NOT RATED) - YES Securities

ICICI Lombard - Q1 FY22 Result Report - YES Securities

Hindustan Unilever - Q1 FY22 Result Report - YES Securities

Avenue Supermart - Q1 FY22 Result Report - YES Securities

Ultratech Cement - Q1 FY22 Result Report - YES Securities

Havells India - Q1 FY22 Result Report - YES Securities

Polycab India - Q1 FY22 Result Report - YES Securities

Q1FY22 Result Update - Bajaj Auto - ICICI Direct

Q1FY22 Result Update - Sterlite Technologies - ICICI Direct

Q1FY22 Result Update - UltraTech Cement - ICICI Direct

Biocon - Q1FY22 First Cut - ICICI Direct

Gladiator Stocks - Bharti Airtel - ICICI Direct

Q1FY22 Result Update - Rallis India - ICICI Direct

Q1FY22 Result Update - Havells India - ICICI Direct

Q1FY22 Result Update - Syngene International - ICICI Direct

Sterlite Technologies - Q1FY22 First Cut - ICICI Direct

Bajaj Auto - Q1FY22 First Cut - ICICI Direct

UltraTech Cement - Q1FY22 First Cut - ICICI Direct


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020